GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

GMED · Jun 30, 2025

GLOBUS MEDICAL INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]

Inspectable configuration

State dimensions

Filing0001562762-25-000200General Corporate

Capex intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.capex_revenue_ratio

6.25% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

10.45% · OPTIONAL · NOT_ENOUGH_HISTORY

Revenue growthRAWCurrent state valid · history insufficient

Evidence method

Yoy · gp.fundamentals.revenue

18.37% · CORE · NOT_ENOUGH_HISTORY

Inventory pressureRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

103.59% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.operating_margin

10.21% · CORE · NOT_ENOUGH_HISTORY

R&D intensityRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

5.36% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

1.83% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History12 statesHistory building

Sep 30, 20230/7 normalizedLevel 3 Dec 31, 20230/7 normalizedLevel 3 Mar 31, 20240/7 normalizedLevel 3 Jun 30, 20240/7 normalizedLevel 3 Sep 30, 20240/7 normalizedLevel 3 Dec 31, 20240/7 normalizedLevel 3 Mar 31, 20250/7 normalizedLevel 3 Jun 30, 20250/7 normalizedLevel 3 Sep 30, 20256/7 normalizedLevel 3 Dec 31, 20256/7 normalizedLevel 3 Mar 31, 20266/7 normalizedLevel 3 Jun 30, 20266/7 normalizedLevel 3

Period transition

What moved in the state?

Capex Intensity Increased

Previous: 6.04%
Current: 6.25%
Delta: 0.21%

Cash Generation Decreased

Previous: 29.64%
Current: 10.45%
Delta: -19.20%

Growth Increased

Previous: -1.41%
Current: 18.37%
Delta: 19.77%

Inventory Pressure Decreased

Previous: 110.95%
Current: 103.59%
Delta: -7.35%

Profitability Decreased

Previous: 16.22%
Current: 10.21%
Delta: -6.01%

R And D Intensity Decreased

Previous: 5.53%
Current: 5.36%
Delta: -0.17%

Sbc Intensity Decreased

Previous: 2.21%
Current: 1.83%
Delta: -0.38%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Transitioned To · GMED Fundamental State →Has State · GLOBUS MEDICAL INC →Transitioned To · GMED Fundamental State →Transitioned To · GMED CAPEX_INTENSITY_INCREASED →Transitioned To · GMED CASH_GENERATION_DECREASED →Transitioned To · GMED GROWTH_INCREASED →Transitioned To · GMED INVENTORY_PRESSURE_DECREASED →Transitioned To · GMED PROFITABILITY_DECREASED →Transitioned To · GMED R_AND_D_INTENSITY_DECREASED →Transitioned To · GMED SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.